articleTop 1% cited

The International Neuroblastoma Pathology Classification (the Shimada system)

Cancer · 1999 · Vol. 86(2) · pp. 364–372

Hiroyuki Shimada✉(Children's Hospital of Los Angeles)Inge M. Ambros(St Anna Children's Hospital)Louis P. Dehner(Barnes-Jewish Hospital)Junichi Hata(Keio University)Vijay Joshi(Hartford Hospital)Borghild Roald(Oslo University Hospital)Daniel O. Stram(Arcadia)Robert B. Gerbing(Arcadia)John N. Lukens(Vanderbilt University Medical Center)Katherine K. Matthay(University of California, San Francisco)Robert P. Castleberry(University of Alabama at Birmingham)

View via DOI Publisher page

Abstract

The International Neuroblastoma Pathology Classification, a system based on a framework of the Shimada classification with minor modifications, is proposed for international use in assessing NTs.

Neuroblastoma Research and Treatments Neurofibromatosis and Schwannoma Cases Adrenal and Paraganglionic TumorsMedicineNeuroblastomaPathologyBiology

MeSH terms

Brain NeoplasmsChildChild, PreschoolGanglioneuromaHumansInfantInfant, NewbornNeoplasm StagingNeuroblastomaPrognosisSurvival AnalysisGanglioneuroblastoma

Citations

1,021

FWCI

15.76

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report